FFCP PHASE2:Hg19::chr5:103559757..103559775,+
From FANTOM5_SSTAR
Revision as of 08:25, 30 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr5:103559757..103559775, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr5:103559757..103559775, + |
Coexpression cluster: | C185_small_adrenal_gastric_Mesenchymal_acute_HES3GFP_testis |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr5:103559757..103559775+ |
---|
0.0
1.0
2.0
3.0
4.0
5.0
6.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
histiocytoma | 7.05e-34 | 2 |
malignant fibroxanthoma | 7.05e-34 | 2 |
lung small cell carcinoma | 7.35e-18 | 4 |
connective tissue cancer | 2.74e-12 | 6 |
musculoskeletal system cancer | 2.74e-12 | 6 |
bronchus cancer | 8.16e-11 | 7 |
bronchogenic carcinoma | 8.16e-11 | 7 |
lung carcinoma | 1.04e-08 | 9 |
lymphoma | 6.13e-08 | 10 |
Showing 1 to 9 of 9 entries